Navigation Links
Wal-Mart Foundation Announces $1 Million Grant to the Meharry Medical College Center for Women's Health Research
Date:11/13/2007

Grant Will Further Research Addressing Health Disparities

NASHVILLE, Tenn., Nov. 13 /PRNewswire-FirstCall/ -- The Wal-Mart Foundation announced today a $1 million grant to the Meharry Medical College Center for Women's Health Research, the nation's only center dedicated to the study of health disparities among women of color. Over the next five years, the grant will help advance the Center's work in addressing diseases that disproportionately impact women from ethnic minorities -- particularly African American women.

"The Meharry Medical College Center for Women's Health Research is leading the way in understanding the health disparities faced by women of color and how those disparities can be eradicated," said Linda Dillman, executive vice president, Risk Management, Benefits and Sustainability at Wal-Mart Stores, Inc., at an event today announcing the grant. "Our Foundation is proud to support their work and community outreach with this grant."

Dillman presented the $1 million check today to Wayne J. Riley, M.D., M.P.H., MBA, FACP, president and chief executive officer, Meharry Medical College, and Valerie Montgomery Rice, M.D., senior vice president for Health Affairs, dean, School of Medicine, and executive director, Center for Women's Health Research, Meharry Medical College.

"We are especially pleased to have the philanthropic support of the Wal-Mart Foundation as it assists us in realizing our vision of eliminating healthcare disparities through education, research and patient care," said Dr. Riley.

"Innovative research and clinical studies at the Center are giving us greater insight as to why women of color are more likely to develop certain diseases and how biology, race, and economics contribute to disparities in women's health care," said Dr. Montgomery Rice. "This grant from the Wal-Mart Foundation will allow us to expand that critical research and broaden our educational awareness programs and community partici
'/>"/>

SOURCE Wal-Mart Stores, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
2. Wal-Mart Foundation Provides Brenau University $250,000 Health Care scholarships Grant for Hispanic Women
3. Red Cross Receives $250,000 From Wal-Mart to Assist With Southern California Wildfire Relief Efforts
4. HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053
5. HearAtLast Teams Up with American Express and Wal-Mart to Conquer Hearing Loss
6. National Patient Safety Foundation Partners with Vocera Communications
7. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
8. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
9. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
10. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
11. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)..., ANN ARBOR, Mich.---The University of Michigan ...f Health to develop the world,s leading resource o...ng compounds that will ultimately take computer-ai...will house the data needed to improve computer pro...ial new drugs, said Heather Carlson, associate pro...
(Date:10/10/2008)... SUNNYVALE, Calif., Oct. 10 /PRNewswire-FirstCa...obal leader in the field of radiosurgery,today an...quarter fiscal,year 2009, ending September 27, 200... closes., A conference call to review the results...ill be hosted by Euan S. Thomson, Ph.D., president...
(Date:10/10/2008)... BALTIMORE, Oct. 10 /PRNewswire/ -- A nationall...treatment strategies for patients with breast,canc...reast Cancer,Strategies: From Biomarkers to Treatm...ness Month., It is challenging for practicing onc...s to stay up to date on the latest patient care,ad...
(Date:10/9/2008)... Let Them Hear Foundation hosts annual wine auc...amily venture, EAST PALO ALTO, Calif., Oct. 9 /PR...ls, California vintners, and local businesses and,...living in silence at the,fifth annual Crush the Si...Foundation at the Four Seasons Hotel, Silicon Vall...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2Health News:Local Leaders Support Needy Individuals, Communities 2
...oject that allowed prisoners a safe way to sport t... ended in September 2006. Now, an AIDS activist ha...awa, outlining the benefits of tattoo parlors in p... of AIDS. It is estimated that nearly 17% of the ...
...ndful of nutrient-rich dried plums each day help k...s in postmenopausal women with osteoporosis or ost...y in the Florida State University College of Human...ssor Bahram H. Arjmandi is the principal investiga...
...s at the University of Pennsylvania School of Medi... of therapy for patients who suffer from high chol... issue of the New England Journal of Medicine (NEJ...ygous familial hypercholesterolemia (FH), a high-r...
...rich food and lack of exercise is lethal for the l...d as fatty liver disease,// it is characterized by...ebilitates the liver and could be a cause of scarr... liver. According to researchers, sedentary habit...
Other Medicine News:Health News:Can Prunes Reverse Bone Loss After Menopause? 2Health News:Can Prunes Reverse Bone Loss After Menopause? 3Health News:New Therapy to Treat Patients With Severely Elevated Cholesterol Levels 2Health News:New Therapy to Treat Patients With Severely Elevated Cholesterol Levels 3
(Date:10/9/2008)...ire-FirstCall/ -- Diamyd Medical reports,that the ...England Journal,of Medicine, has published an arti...iamyd(R) diabetes vaccine for type 1 diabetes., (...4/297194 ), The article is now available on the ...l be in print on October 30. It presents the,resul...
(Date:10/8/2008)...ers Research That May Offer New Hope to,Heart Fail...ionally, over 3,000 people are,waiting for a heart... half,of those will receive a transplant. Now, pio...is paving the way for how to treat congestive hear... News Release, go to:, http://www.prnewswire.com/m...
(Date:10/8/2008)...y of Poly-ICR as Vaccine Adjuvant, SAN DIEGO, Oct...icals,Corporation (TSX: NVN) today presented posit...etary Toll-like Receptor 3 agonist, Poly IC-Poly,A...2008 in Lyon, France.,Study results demonstrated P...the Toll-like Receptor 3 (TLR3) pathway. Data show...
(Date:10/7/2008)...ire/ -- McLaren Health Care and its Great,Lakes Ca...eading medical,minds to share the latest work unde...al cancer treatments. The October 11th symposium, ...en,s Sukamal Saha, M.D., an,award-winning surgical...r,colorectal cancer has gained worldwide recogniti...
Breaking Medicine Technology:Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2AARP Calls for Action on Top Consumer Priorities 21189 1AARP Calls for Action on Top Consumer Priorities 21189 2Death on the Net 3F Over 60 25 of Medicines Sold by Online Pharmacies are Fake 21187 1Death on the Net 3F Over 60 25 of Medicines Sold by Online Pharmacies are Fake 21187 2Death on the Net 3F Over 60 25 of Medicines Sold by Online Pharmacies are Fake 21187 3OrthoSynetics 28TM 29 Donates Body Armor to New Orleans Police Department 21185 1OrthoSynetics 28TM 29 Donates Body Armor to New Orleans Police Department 21185 2AHCA Alliance Praise New Bipartisan Bi Cameral Effort Urging Bush Administration to Forego Medicare Cuts 21183 1AHCA Alliance Praise New Bipartisan Bi Cameral Effort Urging Bush Administration to Forego Medicare Cuts 21183 2AHCA Alliance Praise New Bipartisan Bi Cameral Effort Urging Bush Administration to Forego Medicare Cuts 21183 3
...ire-FirstCall/ -- IDM,Pharma, Inc. today announced... clinical trial and data from the Phase II EP-2101...al trial will be,presented at the 2007 American So...ing in Chicago on June 1-5 2007. , , UVIDEM pre...ogical responses in patients with malignant, ...
...rstCall/ -- Lev,Pharmaceuticals, Inc. ("Lev" or th... patient treatment in the prophylactic portion of,...tor (C1-INH) for,hereditary angioedema (HAE). The ...aluated the efficacy and safety of C1-INH,replacem...rophylactic treatment to prevent HAE attacks. , Le...
Other Medicine Technology:IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 2IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 3IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 4IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 5IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 6Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 2Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 3Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 4
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: